30 September 2024
Cirata plc
("Cirata" or the "Company")
HCSC Contract Renewal
Cirata plc (LSE: CRTA) is pleased to announce that the Health Care Service Corporation (HCSC) has renewed its existing contract for Cirata's Fusion product for a period of 12 months. The total consideration for the term is $983,010. The use case supports HCSC disaster recovery for on-premises Hadoop data moving to Microsoft Azure cloud. Fusion is a data migration product.
This announcement contains inside information under the UK Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Cirata plc is Larry Webster, Company Secretary.
For further information, please contact:
|
Cirata |
+1 (925) 380 1728 |
|
Stephen Kelly, Chief Executive Officer |
|
|
Ijoma Maluza, Chief Financial Officer |
|
|
Daniel Hayes, Investor Relations |
|
|
|
|
|
FTI Consulting |
+44 (0)20 3727 1137 |
|
Matt Dixon / Kwaku Aning / Usama Ali |
|
|
|
|
|
Stifel (Nomad and Joint Broker) |
+44 (0)20 7710 7600 |
|
Fred Walsh / Ben Good / Sarah Wong |
|
|
|
|
|
Panmure Liberum (Joint Broker) |
+44 (0)20 3100 2000 |
|
Max Jones / John More |
|
About Cirata
Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
